CoChat

Angiotensin‐converting enzyme 2 antagonizes angiotensin II‐induced pressor response and NADPH oxidase activation in Wistar–Kyoto rats and spontaneously hypertensive rats

Open access
Lo, Jennifer, Patel, Vaibhav B., Wang, Zuocheng, Levasseur, Jody, Kaufman, Susan, Penninger, Josef M., Oudit, Gavin Y. · 2013 · Experimental Physiology
Cited by 64

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

New Findings: What is the central question of this study? Angiotensin‐converting enzyme 2 (ACE2), an enzyme which converts angiotensin II (Ang II) into angiotensin‐(1–7) [Ang‐(1–7)] and terminates the effects of Ang II, is a negative regulator of activated renin‐angiotensin system (RAS). Cardiac overexpression of ACE2 has shown conflicting results on myocardial fibrosis in contrast to marked anti‐ hypertensive and anti‐remodelling properties. What is the main finding and its importance? Recombinant hACE2 administration attenuates oxidative stress, NADPH oxidase activity and ERK1/2 signalling and high blood pressure confirming its beneficial role in two rat models of hypertension. Angiotensin‐converting enzyme 2 (ACE2), a monocarboxypeptidase capable of metabolizing angiotensin II (Ang II) into angiotensin‐(1–7) [Ang‐(1–7)], has emerged as a potential therapeutic target. We hypothesized that ACE2 is a negative regulator of Ang II‐mediated pathological effects in vivo. In Wistar–Kyoto (WKY) rats, Ang II infusion (0.1 μg min−1 kg−1) induced a pressor response, activation of NADPH oxidase and generation of superoxide in the heart, kidney and blood vessels; these effects were significantly blunted by recombinant human ACE2 (rhACE2; 2 mg kg−1), in association with a lowering of plasma Ang II and elevation of Ang‐(1–7) levels. In the spontaneously hypertensive rat (SHR) model, rhACE2 (2 mg kg−1 day−1) delivered over a 14 day period partly corrected the hypertension, the NADPH oxidase activation and the increased superoxide generation in the heart, kidney and blood vessels. Treatment with rhACE2 inhibited Ang II‐mediated phosphorylation of the myocardial extracellular signal‐regulated kinase 1/2 pathway in WKY rats, with congruent results seen in SHR hearts. Hence, rhACE2 is an important negative regulator of the Ang II‐induced pressor response and NADPH oxidase activation and suppresses pathological myocardial signalling, thereby providing a novel therapeutic agent with which to antagonize an activated renin–angiotesin system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1113/expphysiol.2012.067165

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Lo, J., Patel, V. B., Wang, Z., Levasseur, J., Kaufman, S., Penninger, J. M., & Oudit, G. Y.
Venue
Experimental Physiology
Publisher
Wiley
Published
2012-07-27
Volume
98
Issue
1
Pages
109-122
ISSN
  • 0958-0670 (ISSN-L)
  • 1469-445X
OpenAlex
W2159415544
Cited by
64
References
6
FWCI
3.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.